SCHEMBL7810474

SCHEMBL7810474

O=C1c2ccncc2-c2nn(CCNCCO)c3ccc(NCCNCCO)c1c23

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 7/20 0.68
TOP2B Q02880 1/20 0.48
BLM P54132 5/20 0.41
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
TP53 P04637 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
USP2 O75604 3/20 0.41
LMNA P02545 3/20 0.41
MAPK1 P28482 3/20 0.41
RECQL P46063 3/20 0.41
NSD2 O96028 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP3A4 P08684 2/20 0.41
CSNK2A1 P68400 2/20 0.41
NPC1 O15118 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
CACNA1F O60840 1/20 0.41
SLC22A3 O75751 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804428 0.96 TOP2A (0.68) TOP2ATOP2BBLMMEN1KMT2A
Nortopixantrone SCHEMBL7804438 0.94 TOP2A (0.61) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7810460 0.94 TOP2A (0.61) TOP2ATOP2BBLMMEN1KMT2A
Nortopixantrone SCHEMBL29385196 0.94 TOP2A (0.61) TOP2ATOP2BBLMMEN1KMT2A
Nortopixantrone SCHEMBL29711469 0.94 TOP2A (0.60) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7804649 0.94 TOP2A (0.60) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7812099 0.94 TOP2A (0.60) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7804761 0.94 TOP2A (0.60) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7811716 0.93 TOP2A (0.59) TOP2ATOP2BBLMMEN1KMT2A
SCHEMBL7804772 0.91 TOP2A (0.57) TOP2ATOP2BBLMMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP claimed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP claimed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US claimed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO claimed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP claimed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO claimed
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed